Insider Trading April 2, 2026

DocuSign CEO Allan Thygesen Disposes of $1.25M in Shares Amid Mixed Analyst Signals

Thygesen sold 26,250 DOCU shares across three trades; analysts and hedge funds weigh in as stock trades near $48

By Avery Klein DOCU
DocuSign CEO Allan Thygesen Disposes of $1.25M in Shares Amid Mixed Analyst Signals
DOCU

DocuSign President and CEO Allan C. Thygesen sold 26,250 shares of the company's common stock on April 1, 2026, generating roughly $1.25 million in proceeds. The transactions were executed in three tranches at prices between $45.89 and $48.38 and were carried out under a Rule 10b5-1 plan. Following the sales Thygesen retains direct ownership of 152,237 shares. The moves come against a backdrop of a 29% year-to-date decline in DocuSign shares, analyst downgrades and price-target reductions, ongoing product integrations, and activist short positions.

Key Points

  • Allan C. Thygesen sold 26,250 DocuSign shares on April 1, 2026, in three transactions totaling roughly $1.25 million; sales were executed under a Rule 10b5-1 plan.
  • After the sales Thygesen directly owns 152,237 shares; DocuSign shares are down 29% year-to-date and trading at $48.37.
  • Analysts have expressed caution: BofA initiated coverage with an underperform rating; RBC and UBS lowered price targets to $55 and $54 respectively; hedge fund short positions add further market pressure. The Slack integration is a recent product development.

DocuSign Inc. President and Chief Executive Allan C. Thygesen liquidated 26,250 shares of the e-signature company's common stock on April 1, 2026, collecting about $1.25 million in gross proceeds. The disposition unfolded in three discrete transactions, with execution prices spanning from $45.89 to $48.38.

The first of the three trades was for 2,700 shares, executed at prices ranging from $45.89 to $46.84. The second tranche consisted of 6,100 shares sold at prices between $46.92 and $47.91. The largest block, 17,450 shares, was sold at prices from $47.92 to $48.38. Company filings indicate that the sales were made pursuant to a Rule 10b5-1 trading plan.

Following these sales, Thygesen directly holds 152,237 shares of DocuSign common stock.

The transactions occur while DocuSign shares have fallen 29% year-to-date and were trading at $48.37. According to InvestingPro analysis cited in company-related materials, the stock appears undervalued at current levels, with a Fair Value assessment suggesting upside potential. The InvestingPro platform also provides a Pro Research Report on DocuSign as part of a library of more than 1,400 research reports.


Analyst activity and market context

Investor sentiment around DocuSign has been mixed in recent updates from equity research desks. BofA Securities initiated coverage of the company with an underperform rating, citing concerns about the trajectory of the company as the eSignature market approaches maturity. Meanwhile, RBC Capital lowered its price target for DocuSign to $55 from $70 after the company reported fourth-quarter results that beat expectations but included operating margin guidance that was modestly below par. UBS also reduced its price target to $54 from $75 and kept a Neutral rating, flagging worries about growth prospects. In its note, UBS referenced valuation metrics including a multiple of eight times CY26 free cash flow for DocuSign.

Separately, hedge fund founder Eric Jackson has taken short positions in DocuSign and other software firms, pointing to research that suggests companies frequently discussing artificial intelligence may underperform peers. These short positions add another layer of market pressure and reflect skepticism among some market participants.


Product developments

On the product front, DocuSign announced an integration with Slack that allows users to create and manage contracts directly within the Slack messaging environment. The integration is designed to enable teams to generate agreements, collaborate on negotiations and complete signing processes without leaving the messaging platform.


What the filings show

The sale transactions were documented as taking place under an existing Rule 10b5-1 plan. The filings show the precise share counts and price ranges for each tranche and the post-sale executive ownership figure. No further changes to insider ownership beyond the disclosed post-sale share count were identified in the filings.


Bottom line

DocuSign's chief executive executed a planned sale of 26,250 shares on April 1, 2026, under a Rule 10b5-1 plan, realizing approximately $1.25 million. The company faces downward price pressure year to date, recent analyst downgrades and price-target reductions, and active short interest from at least one hedge fund founder, even as it pursues integrations such as the Slack partnership and receives positive fair-value commentary from InvestingPro.

Risks

  • Market maturation risk in the eSignature sector cited by analysts - impacts enterprise software and SaaS market segments.
  • Analyst downgrades and price-target cuts could weigh on investor sentiment and share price - impacts capital markets and institutional investor positioning.
  • Short positions by hedge funds and negative research narratives about AI-related rhetoric may exert additional downward pressure - impacts equity trading dynamics in software stocks.

More from Insider Trading

National CineMedia General Counsel Sells $36,680 in NCMI Stock Amid Recent Vesting Apr 2, 2026 Adaptive Biotechnologies COO Sells $553,693 in ADPT Stock as Options Are Exercised; Adeptus Posts Q4 Beat Apr 2, 2026 Zenas BioPharma Director Buys $70,197 in Stock as Company Advances Clinical and Financing Plans Apr 2, 2026 Accel Entertainment CEO Disposes of $497K in Stock as Company Posts Strong Q4 Results Apr 2, 2026 Axcelis CEO Executes $117K Sale; Company Posts Strong Quarter Amid Leadership Moves Apr 2, 2026